A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients Anna Isabella Pisani,...

Improving quality, affordability, and equity of multiple sclerosis care Annette Langer-Gould, Shilpa Klocke, Brandon Beaber, Sonu M....

Paper #1: Promoting remyelination in multiple sclerosis Nick Cunniffe and Alasdair Coles Journal of Neurology (2021) 268:30–44...

Paper #1: Leptin levels are associated with multiple sclerosis risk Martin Biström , Johan Hultdin , Oluf Andersen et al Multiple...

Multiple sclerosis and aging: comorbidity and treatment challenges Aiora Ostolaza *, Jon Corroza, Teresa Ayuso Multiple Sclerosis and...

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis Christina Krienke, Laura Kolb, Elif Diken et al...

Paper #1 - Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter Antonio Luchicchi, PhD, Bert’t Hart, PhD, Irene...

The causal role of circulating vitamin D concentrations in human complex traits and diseases: a large-scale Mendelian randomization study...

Bottom Line: Multiple sclerosis is a heterogeneous disease. It is, in my opinion, a syndrome like pneumonia, that is an illness with...

Paper #1: De novo design of picomolar SARS-CoV-2 miniprotein inhibitors Longxing Cao, Inna Goreshnik, Brian Coventry, et al. Science 370,...

Paper #1: Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review Alexander, S., Peryer, G., Gray, E.,...

Paper #1: Silent Progression in Disease Activity–Free Relapsing Multiple Sclerosis University of California, San Francisco MS-EPIC Team,...

Bottom Line: Recent work in persons with MS suggests that the gut microbiome (the population of bacteria in the gut) is altered in MS,...

A list of summarized articles is at the end of this posting. Bottom Line: There are at least four critical questions that persons with MS...

Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. Factor DC, Barbeau AM, Allan KC, et al. Cell....

Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis....

Paper #1: Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture. Roman...

Treatment Considerations in the Radiologically Isolated Syndrome. Makhani N. Curr Treat Options Neurol. 2020;22:3....

Paper #1: An overview of the current state of evidence for the role of specific diets in multiple sclerosis. Evans E, Levasseur V, Cross...

Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors. Sepulveda...